Advertisement
Loading...

HUTCHMED (China) Limited

HCM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$12.51
$-0.18(-1.42%)
U.S. Market opens in 28h 26m

HUTCHMED (China) Limited (HCM) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio4.78
EPS (TTM)$2.65
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$13.70
3 Months$16.68
1 Year Target$15.72

HCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 26.50, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $15.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.78 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.42%
5-Day Change
-5.37%
1-Month Change
-18.24%
3-Month Change
-15.24%
6-Month Change
-17.04%
Year-to-Date (YTD) Change
-6.15%
1-Year Change
-4.43%
3-Year Change
-12.27%
5-Year Change
-53.23%
All-Time (Max) Change
-7.33%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

1,811 Employees
IPO DateMar 16, 2016
CountryHK
Actively Trading

Frequently Asked Questions